Reuters logo
BRIEF-US DTRA to fund preclinical work on Evolva's antibiotic GC-072
August 14, 2014 / 5:35 AM / 3 years ago

BRIEF-US DTRA to fund preclinical work on Evolva's antibiotic GC-072

Aug 14 (Reuters) - Evolva Holding SA : * US DTRA to fund preclinical work on evolva’s antibiotic gc-072 * Entered into contract with US DTRA for program gc-072: first oral antibiotic

for the treatment of acute melioidosis and select agents * Says DTRA will fund $6.5 million for first 15-month stage and up to

additional $8.6 million if two remaining stages are executed * Source text for Eikon * Further company coverage

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below